临床试验

CHAMPION-AF Clinical Trial

NCT：NCT04394546 · ACTIVE_NOT_RECRUITING

NCT编号NCT04394546

状态ACTIVE_NOT_RECRUITING

开始日期2020-10-15

SponsorBoston Scientific Corporation (INDUSTRY)

First posted2020-05-19

Last updated2026-09-11

简要摘要

The primary objective of this study is to determine if left atrial appendage closure (LAAC) with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。